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Dermal Absorption of a Dilute Aqueous Solution of Malathion 
 
John E. Scharf, MD 
 
ABSTRACT 
 
 
 
Malathion is a commonly used organophosphate pesticide on field crops, fruits, nut trees, 
vegetables, livestock, agricultural premises, and land. The approved uses also include 
mosquito and medfly control. These uses can result in human skin contact.  The purpose 
of this study is to evaluate the human skin absorption of malathion for the purpose of 
assessing the risks associated with aqueous solution exposures following applications. 
Aerial applications can result in solubilized malathion in swimming pools and other 
waters that may be contacted. Human volunteers were selected and exposed to aqueous 
solutions of malathion at various concentrations. Participants submerged their arms and 
hands in twenty liters of dilute malathion solution in either a stagnant or stirred 
environment. The “disappearance method” was applied by measuring malathion 
concentrations in the water before and after human subject exposure to the water for 
various periods of time. Malathion was measured using Gas Chromatography. No 
measurable skin absorption was detected in 42% of the participants.  Measurable skin 
absorption among the remaining 58% of participants resulted in doses that were more 
than an order of magnitude less than the minimal dose necessary to cause a measurable 
change in red blood cell acetylcholinesterase (RBC-AChE). Extrapolation of these results 
to a mathematical model for recreational swimmers and bathers exposed to contaminated 
swimming pools and surface waters typically detected after bait application again are an 
order of magnitude below the doses needed to cause a detectable change in RBC-AChE. 
These data indicate that exposure to aqueous malathion following usual aerial bait 
applications is not appreciably absorbed, and therefore, it is not a public health hazard.                         
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Chapter One 
 
Organophosphate Pesticides 
 
Introduction.  The use of organophosphate compounds as insecticides began in the 1930s 
and has increased markedly since many organochlorine insecticides were banned in the 
1970s. In contrast to organochlorine insecticides, organophosphate insecticides degrade 
rapidly in the environment and do not accumulate or concentrate in the food chain. Thus, 
organophosphates have less potential for chronic health effects or environmental 
contamination than do organochlorines and pose less risk to consumers of food products. 
However, organophosphate compounds have a greater potential for acute toxicity in 
humans than do chlorinated compounds. Even among the organophosphate pesticides, 
however, a wide spectrum of potency exists. As insects develop greater resistance, the 
trend is to use more potent, and consequently, more lipid-soluble and longer-lasting 
insecticides.      
 
Malathion has a generally low mammalian toxicity in spite of its strong insecticidal 
properties. Malathion itself has little or no cholinesterase activity. Like many other 
organophosphates, malathion is activated by mono-oxygenase attack to produce the 
potent anticholinesterase malaoxon. Malathion and malaoxon are rapidly detoxified in 
mammals by carboxylesterase attack (but not insects) to produce their respective 
monacids. If the carboxylesterase detoxification pathway is inhibited, mammals may be 
made almost as sensitive as insects to malathion (Caldwell, 1983).    
 
Malathion is metabolized in human liver by one of two pathways: (1) hydrolysis to non-
toxic metabolites; or (2) oxidation to the active metabolite, malaoxon.  Malaoxon has 68x 
the inhibition of plasma cholinesterase activity as malathion.  Furthermore, malaoxon is 
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generally acknowledged to be the actual inhibitor of plasma cholinesterase and to be the 
primary compound responsible for the full spectrum of cholinergic symptoms observed in 
poisoned subjects.  Normally, the balance of metabolic reactions in the gut is heavily in 
favor of oxidation to malaoxon in insects, but favors hydrolysis to non-toxic metabolites 
in humans; thus the selective toxicity of malathion on insects vs. humans. 
 
Physical Properties.  In organophosphate molecules, R1 and R2 are usually alkyl groups 
(typically ethyl or methyl). X is commonly an alkyl group that is replaced by a hydrogen 
atom during irreversible inhibition, or “aging”, of the organophosphate-enzyme complex. 
 
 
 
           O  (or S) 
            || 
R1O---P---OR2 
            | 
           O---X 
 
Figure 1: Organophosphate. 
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   S 
   || 
CH3O---P---OCH3 
   | 
  S---CHCOOC2H5 
         | 
        CH2COOC2H5 
 
Figure 2: Malathion. 
 
• Appearance: Clear, amber liquid with penetrating garlic odor. 
• Chemical Name: diethyl (dimethoxy thiophosphorylthio) succinate 
• CAS Number: 121-75-5 
• Molecular Weight: 330.36 
• Water Solubility: 130 mg/L 
• Solubility in Other Solvents: very soluble 
• Melting Point: 2.85 C 
• Vapor Pressure: 5.5 x 10-6 mmHg at 20°C 
• Log Kow Partition Coefficient: 2.75 
• Specific Gravity: 1.23 
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  O 
   || 
CH3O---P---OCH3 
   | 
  S---CHCOOC2H5 
         | 
        CH2COOC2H5 
 
Figure 3: Malaoxon. 
 
• Appearance: Colorless, oily liquid. 
• Chemical Name: diethyl ((dimethoxy phosphinyl) thio) butanedioate 
• CAS Number: 1634-78-2 
• Molecular Weight: 314.36 
• Water Solubility: 209 mg/L 
• Soluble in ethanol, methanol and acetone.  
• Melting Point: < 20 C 
• Vapor Pressure: 9.8 x 10-6 mmHg 
• Log Kow Partition Coefficient: 2.02 
• Specific Gravity: 1.23 
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  O 
   || 
CH3S---P---OCH3 
   | 
  S---CHCOOC2H5 
         | 
        CH2COOC2H5 
 
Figure 4: Isomalathion. 
 
 
 
 
  O 
   || 
CH3O---P---OCH3 
   | 
   SCH3 
 
Figure 5: O,O,S-trimethyl phosphorothioate. 
 
 
 
 CHCOOC2H5 
 | | 
 CH2COOC2H5 
 
Figure 6: Diethyl Fumarate. 
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           S 
           || 
CH3CH2O---P---OCH2CH3 
           | 
          O 
           | 
          Benzene – NO2 
 
Figure 7: Parathion. 
 
• Appearance: Deep brown to yellow liquid with a faint odor of garlic.  
• Chemical Name: O,O-diethyl O-4-nitrophenyl phosphorothioate  
• CAS Number: 56-38-2  
• Molecular Weight: 291.3  
• Water Solubility: 24 mg/l 
• Soluble in alcohols, oils, ethers.  
• Melting Point: 6 C  
• Vapor Pressure: 1.9 x 10-5 mm Hg  
• Log Kow Partition Coefficient: 3.83  
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Figure 8: Chlorpyrifos. 
 
• Appearance: Amber to white crystalline solid with a mild sulfur odor.  
• Chemical Name: O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate  
• CAS Number: 2921-88-2  
• Molecular Weight: 350.62  
• Water Solubility: 2 mg/L  
• Soluble in benzene, acetone, chloroform, ethers.  
• Melting Point: 44 C  
• Vapor Pressure: 2.5 mPa  
• Log Kow Partition Coefficient: 4.70  
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  O 
   || 
CH3S---P---OCH3 
   | 
   NH2 
 
Figure 9: Methamidophos. 
 
• Appearance: Crystalline solid, with off-white color and pungent odor.  
• Chemical Name: O,S-dimethyl phosphora-midothiolate  
• CAS Number: 10265-92-6  
• Molecular Weight: 141.12  
• Water Solubility: 90 g/L  
• Solubility in solvents unavailable.  
• Melting Point: 44 C  
• Vapor Pressure: 3 x 10-4 mmHg  
• Log Kow Partition Coefficient: NA  
 
 
(Extoxnet, 2003). 
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Table 1: Physical Properties and Partition Coefficients (K) of Malathion vs. Malaoxon. 
 
System    Malathion  Malaoxon 
Lipid Solubility   More soluble  Less soluble  
Log Kow      2.75   2.02 
Log K Chloroform-water  64   5.8 
Log K Hexane-water   19   0.42 
Log K Petroleum ether-ethanol 11   1.8 
Log K CCl4-water   39   2.9 
Cuticle Penetration   Better   Worse 
Alkaline Hydrolysis Stability  More stable  Less stable 
AntiAChE activity   Poor   Good 
I50 Inhibit AChE Conc. (M)  1 x 10-4  4 x 10-7 
 
Oxidation of malathion to malaoxon greatly increases partitioning into polar solvents, but 
less likely to penetrate skin (O’Brien, 1957) (Miller, 1998). 
 
Exposure Pathways.  The site of introduction of a xenobiotic into the organism 
qualitatively governs the initial exposure. An orally administered compound has to 
traverse the intestines, the liver, and the lung before it reaches the systemic circulation. 
Due to this ‘first-pass effect’, the amount that reaches the systemic circulation is much 
less than the amount administered. In contrast, this ‘first-pass effect’ is bypassed through 
dermal absorption. The entire amount systemically absorbed through the skin is passed 
through the lungs by the venous blood before it is retuned to the heart and distributed by 
arterial blood to the vital organs (Caldwell, 1983).    
 
Most exposures to organophosphates occur from skin absorption. Skin absorption can 
occur when dermal contact is made during handling and application, and when contact is 
made with chemical residues on plants, fruits, and foliage; in soil; and in dust particles 
after spraying. Organophosphate insecticides such as malathion are applied in the sulfur-
containing (-thion) form, but readily undergo desulfuration to form a more toxic oxygen-
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containing (-oxon) form. In the field, this conversion occurs slowly under the influence of 
oxygen and light, producing residues with altered physical properties and potentially 
more toxic as well.   
 
Biologic Fate.  Skin absorption of malathion is incomplete because much of the applied 
dose is lost from the skin surface by washing, evaporation and gradual exfoliation of the 
outer layers of the stratum corneum. The amount absorbed into the body depends on a 
relationship between the speed with which it penetrates the skin and the speed with which 
it is lost from the skin surface. Importantly, systemic absorption after skin application can 
be delayed, and the resultant absorption rate across skin is much slower than across 
mucous membranes. Typically, experimental subjects differ by a factor of five in the 
amount of malathion percutaneous penetration, with standard deviations up to one half 
the mean value. Thus, assuming a normal distribution, one person in ten will absorb twice 
the mean value, while one in twenty will absorb three times that amount.   
 
Dary exposed human forearms to 1% malathion aqueous solution, placing an occlusive 
patch over the exposure site after 4 hours of observation. This occlusive patch was 
removed at 24 hours, analysis of which revealed 65% of the applied dose. This amount in 
the occlusive patch may represent evaporative and mechanical loss potential. Preliminary 
mass balance over the initial 24-48 hour post-exposure period was as follows: 
• 70% of initial applied dose removed by washing skin surface-epidermis;  
• 40% of the remaining dose (12% of initial dose) slowly lost through evaporation; 
• 60% of the remaining dose (18% of initial dose) retained in dermis; 
• 90% of the dermal to systemic dose is eliminated in urine; 
• 15% of the initial applied dose is systemically absorbed and eliminated in urine. 
The slow rate of dermal absorption and efficient rate of elimination by liver 
carboxylesterases and kidneys reduce the risk of acute toxicity; however, repeated 
exposures could burden these same organs of metabolism and elimination (Dary, 1994).  
 
Although the skin is often considered as merely acting as a passive barrier to the entrance 
of chemicals, it is clearly capable of metabolizing endogenous substances as well as 
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drugs and other exogenous chemicals. Despite the low activity of metabolic enzymes in 
skin, it must be appreciated that skin is the largest organ in the body, comprising 5% of 
total body weight. Thus, the skin can contribute significantly to total metabolism of 
chemicals. For example, skin is well known to contain cytochrome P-450, NADPH-
cytochrome c-reductase and glutathione S-transferase. Cutaneous enzymes with mono-
oxygenase activities such as these can be induced by a variety of xenobiotics. 
Immunohistochemical investigations have documented the epidermis, sebaceous glands, 
and hair follicles as the sites of xenobiotic activation and detoxification within the skin 
(Caldwell, 1983).    
 
Parathion, a closely related organophosphate to malathion, has demonstrated unusual 
percutaneous absorption kinetics and systemic toxicity patterns. For example, in an 
isolated perfused porcine skin flap model of parathion, almost 70% of the parent 
compound parathion penetrated the skin into the perfusate as paraoxon. Thus, 
biotransformation of topically dosed organophosphates by skin-based cytochrome p450 
enzymes to the more toxic –oxon form may play a crucial role in risk assessment (Carver 
1988) (Kao, 1990).  
 
In the mammal, vigorous hepatic hydrolytic degradation of organophosphates at the 
carboxylic ester link typically outstrips the process of accumulation caused by oxidation. 
Hepatic conversion is brought about chiefly by microsomal esterases. This hydrolyzing 
system of the liver is more active against malathion than malaoxon; ultimately, however, 
both –thion and –oxon forms are metabolized to non-toxic alkyl phosphate mono-acids 
and excreted rapidly. In the rat model, after oral malathion ingestion, twelve hour urine 
samples contained 1% of the dose as malaoxon mono-acid and 67% as malathion acids 
(Kizer, 1991). On the other hand, in the cockroach insect, both fat body and midgut 
metabolic systems oxidize malathion to malaoxon, but only the fat body hydrolyzes 
malaoxon to the non-toxic alkyl phosphate. In the insect, then, oxidation is much more 
rapid than hydrolysis, thus malaoxon may accumulate steadily to a lethal level (O’Brien, 
1957). 
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Physiologic Effects.  Organophosphates combine with and inhibit cholinesterase 
enzymes, of which acetylcholinesterase (AChE) in nerve tissue is the most important. 
After conversion of malathion to its oxygen analog, malaoxon, the active site of AChE is 
phosphorylated (and inhibited) by dimethyl or methyl phosphate. Inactivation of AChE 
results in accumulation of acetylcholine at the neuroreceptor transmission site, resulting 
in massive overstimulation of the cholinergic system as follows: 
• Accumulation of acetylcholine in the muscarinic autonomic receptors cause 
miosis, tearing, salivation, perspiration, nausea, vomiting and diarrhea.  
• Accumulation of acetylcholine in the nicotinic neuromuscular receptors cause 
fasciculations, cramps and weakness. 
• Rising accumulation of acetylcholine in the central nervous system cause sensory 
and behavioral disturbances, incoordination, depressed cognition, and respiratory 
failure.  
 
Biologic Indicators.  Detection of intact organophosphate compounds in blood is usually 
not possible. In general, organophosphates do not remain unhydrolyzed in the blood more 
than a few minutes. Alkyl phosphate metabolites can often be detected in the urine up to 
48 hours after exposure. The appearance of these urinary metabolites can demonstrate 
pesticide absorption at lower dosages than those required to depress cholinesterase 
activity. Occupational malathion exposures have resulted in dimethyl-dithiophosphate 
(DMDTP) serum concentrations ranging to 3.5 mg/L (Shafnik and Enos, 1969). Up to 
23% of a single oral dose of malathion is excreted in the 16 hour urine as ether-
extractable phosphates, where biological activity was estimated via colorimetry (Mattson 
and Sedlak, 1960).  
 
Red Blood Cell (RBC) cholinesterase, the same enzyme found in the nervous system, is a 
useful surrogate indicator for AChE activity at neuroreceptor sites. RBC cholinesterase 
activity is generally only restored as new red blood cells are formed at 1% per day. 
However, it is notoriously difficult to interpret cholinesterase inhibition without baseline 
values because normal values vary widely. The laboratory normal range is not useful 
because upper and lower limits typically differ by a factor of four. RBC cholinesterase 
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inhibition from 25-50% of the individual’s baseline is generally regarded as evidence of 
toxicity, or the Lowest Observable Adverse Effect Level (LOAEL).  
 
In the best available No Observable Adverse Effect Level (NOAEL) study, volunteers 
ingested 16 mg of malathion daily for 47 days without effect on RBC Cholinesterase. 
Doses of 24 mg, however, when administered for 56 days caused 25% depression of RBC 
cholinesterase, with maximal effects occurring three weeks after administration. No 
clinical signs or symptoms were noted in spite of the RBC cholinesterase depression 
(Moeller and Rider, 1962).  
 
Demyelination and Phospholipid Peroxidation.  In humans and other vertebrates, reaction 
of organophosphates with neuropathy target esterase (NTE) may initiate events which 
culminate in axonal degeneration. Organophosphates inhibit biosynthesis of 
phospholipids which in turn may cause peroxidation of the myelin sheath. Thus, toxic 
organophosphate exposure may result in demyelination-induced neurotoxicity. For 
example, toxic malathion exposure in rats has induced spinal cord phospholipid 
peroxidation (Haque, 1987). 
 
Chlorpyrifos is heavily used for agricultural and domestic purposes due to its persistence 
and relative safety compared to other organophosphate insecticides. Unlike parathion, 
chlorpyrifos evokes delayed neuropathies only with very high exposures. Animal studies 
confirm that chlorpyrifos has an order of magnitude higher systemic toxicity in neonates. 
Perhaps more alarmingly, recent studies in rats have shown that chlorpyrifos, in doses 
below the threshold for symptoms of systemic toxicity, nevertheless can compromise the 
basic cellular processes of brain development.  
 
In the neonate, programming of brain cell reactivity and synaptic connections are at their 
peak and are thus most vulnerable. In the neonate, the adverse effects of cholinesterase 
inhibition are exacerbated by poor synaptic adaptability to cholinergic hyperstimulation. 
In a neonatal rat animal model after chlorpyrifos exposure at doses that do not cause 
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systemic toxicity, there was alteration in coordination skills and locomotor activity (Dam, 
2000).  
 
In a similar neonatal animal model, chlorpyrifos exposure during the period of brain cell 
acquisition and axonogenesis resulted in neuronal loss and abnormalities of 
synaptogenesis. The adverse effects on cholinergic neurotransmission are a particular 
concern since cholinergic pathways are critically important for cognitive function. In fact, 
neonatal exposure in rats produced lasting reductions in hippocampal cholinergic 
presynaptic activity. Short-term behavioral studies in this animal model indicated 
alternations in several activity measures, and additional effects on activity emerged well 
after the end of cholorpyrifos administration (Levin, 2001). 
 
These results (e.g. alterations in behavior and locomotion) stress the importance of 
looking beyond the acute period of organophosphate exposure for adverse effects. 
Indeed, developmental deficits may appear well after organophosphate exposure and 
cholinesterase inhibition have disappeared. 
 
Delayed Neuropathy.  Shortly after organophosphate exposure, a weak reversible bond is 
formed with AChE. With time, however, a more permanent AChE-phosphate bond forms 
(“aging”) that inactivates the enzyme and requires an antidote to break. If an antidote 
such as pralidoxime [2-PAM] is not given within 24-48 hours after exposure, the AChE-
phosphate bond becomes so strong that physiologic recovery depends on de-novo 
synthesis of AChE. At the nerve junction, AChE is restored in an average of two weeks; 
in the body as a whole, it may require up to three months to restore enzyme activity to 
near normal levels (Pope and Rall, 1995). 
 
Symmetric distal axonal degeneration is a systemic health effect caused by some 
organophosphates that is not due to AChE inhibition. The degeneration is a dying back of 
large diameter axons and their myelin sheaths in distal parts of the peripheral nerves and 
in long spinal cord tracts. This degeneration is caused by inhibition of a neuronal, 
nonspecific carboxylesterase known as neuropathic target esterase (NTE), essential for 
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lipid metabolism in neurons. The resulting clinical syndrome, organophosphate-induced 
distal neuropathy (OPIDN), typically begins one to two weeks after exposure, and 
consists of flaccidity, paralysis and paresthesias of the lower extremities.  
 
All organophosphates inhibit acetylcholinesterase (AChE), but only a subset of these 
inhibit neuropathy target esterase (NTE), the enzyme definitively associated with 
OPIDN. In essence, a sufficient amount of NTE must be irreversibly inhibited by the 
organophosphate before the OPIDN syndrome may occur. In vitro (neuroblastoma cells) 
and in vivo (hen, cat, and sheep) testing have established organophosphate-specific NTE / 
AChE inhibition ratios, and correlated this ratio precisely with the ability to produce the 
OPIDN syndrome. Previous work has shown that if AChE / NTE Inhibition Ratio >> 1, 
the dose required for producing OPIDN >> LD50. Accordingly, malathion, parathion, 
chlorpyrifos, dichlorvos and trichlorfon have not been linked to OPIDN. 
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Table 2: Organophosphates, OPIDN, and AChE / NTE Inhibition Ratio. 
 
Organophosphates linked to OPIDN:        AChE / NTE Inhibition Ratio:  
• DFP [diisopropyl fluorophosphonate]              5.3 
• TSP [cyclic tolyl saligenim phosphate]              1.5 
• PSP [cyclic phenyl saligenim phosphate]              0.12 
• Mipafox                  1.1 
• DBVP                   0.81 
• DOVP                   0.56 
• EPN [ethyl nitrophenyl phenylphosphonate] 
• Leptophos 
• Merphos 
• Tri-ortho-cresyl phosphate [TOCP] 
• Tri-ortho-tolyl phosphate [TOTP] 
• Triaryl phosphate 
• Methamidophos 
 
Organophosphates not linked to OPIDN:        AChE / NTE Inhibition Ratio: 
• Parathion       700,000 
• Malathion         76,000  
• Isomalathion (1R, 3R)                   49000 
• Isomalathion (1R, 3S)                 150000 
• Isomalathion (1RS, 3RS)                    9100 
• Isomalathion (1S, 3R)                     2500 
• Isomalathion (1S, 3S)                     1500 
• Chlorpyrifos              200 
• Dichlorvos [DDVP]               42 
• Trichlorfon                68 
(Rosenstock, 1991) (Jianmongkol, 1996)  (Ehrich, 1997).  
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Although there are no known case reports of OPIDN specifically linked to malathion, 
malathion exposure has been listed at least as a contributory factor in a significant 
OPIDN case series examination. In this series, exposed patients had moderate increases 
in vibrotactile thresholds in the lower extremities. These results suggest that previously 
reported OPIDN cases may represent only the worst disease in a spectrum of 
polyneuropathy impairment, a sequelae of organophosphate exposure that may be much 
more common than previously thought (McConnell and Rosenstock, 1994). 
 
To evaluate the latent neurological effects of organophosphate poisoning, an 
epidemiological study matched 100 pairs of individuals with previous acute 
organophosphate poisoning and non-poisoned controls. Ten different organophosphates 
were listed as the cause of primary poisoning, most being parathion, but of which six 
were due to malathion. In the neurological examination component of the study, clear 
abnormalities were demonstrated in the organophosphate exposed group in memory, 
abstraction, mood, motor reflexes and simple motor skills. In the psychological 
examination component, clear abnormalities were demonstrated in intellectual 
functioning, academic skills, abstraction and flexibility in thinking. Minnesota 
Multiphasic Personality Inventory analysis revealed greater distress and complaints of 
disability for the poisoned subjects. Twice as many cases as controls had Halstead-Reitan 
Battery summary scores in the range characteristic of individuals with cerebral damage or 
dysfunction (Savage EP, 1988). 
 
Delayed polyneuropathy (DP) is typically caused by organophosphate induced inhibition 
of NTE, the enzyme essential for normal neuronal and axonal processes. DP is 
characterized as a distal sensori-motor axonopathy, beginning about two weeks after 
toxic exposure, with recovery beginning six to twelve months later. The best available 
case report of malathion-induced delayed polyneuropathy (DP) occurred in 1990 as 
follows:  
 
A 65yo female was admitted to the hospital in cholinergic crises with muscarinic, 
nicotinic and central effects after deliberate ingestion of 100 ml of malathion (235 mg/kg) 
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dissolved in isoproponal. Artificial ventilation, atropine and pralidoxime were initiated 
immediately. The patient was found to have complete and total depression of serum 
cholinesterase. The patient regained consciousness and strength a few days later, and was 
noted to have complete normalization of serum cholinesterase on day 12. Her 
hospitalization was further complicated by pneumonia and acute respiratory distress 
syndrome. At day 10, her muscle strength began to deteriorate again with loss of deep 
tendon reflexes. Distal muscles were more involved than proximal ones. On day 35, a 
gastrocnemius muscle biopsy showed evidence of denervation and reinervation. A sural 
nerve biopsy showed degenerating axons, moderate loss of myelinated fibers and clusters 
of small regenerating axons. Six weeks after admission, muscle strength began to recover 
and was normalized after three months. This patient was found to have exposure to a 
significant pesticide residue as the key DP causative factor: isopropyl-malathion (Argiles, 
1990).       
 
Organophosphate intoxication will cause cholinergic stimulation acutely, but delayed 
neuropsychiatric sequelae may also result in a subacute paralytic syndrome known as the 
intermediate syndrome. Intermediate syndrome is characterized by deterioration of 
muscle strength and mental status about 48 hours after the acute presentation. Typically 
weakness manifests itself within the neck and proximal muscles, which may include the 
cranial nerves and the diaphragm. Motor recovery may take 5-20 days and most patients 
will not develop polyneuropathy. Behavioral manifestations include depression, 
psychosis, aggression, irritability, and memory and concentration problems. The best 
available case report of malathion-induced intermediate syndrome occurred in 1998 as 
follows: 
 
A 44yo female was found in cholinergic crises with muscarinic, nicotinic and central 
effects after deliberate ingestion of 125 ml of malathion (50% solution). Artificial 
ventilation, atropine and pralidoxime were initiated immediately.  Her hospitalization was 
further complicated by bronchorrhea requiring glycopyrollate and pneumonia. She was 
eventually transferred out of intensive care to the medical ward on day 13. On day 23, she 
began displaying agitation, disorientation, hallucinations and somatic delusions. She 
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became aggressive and inappropriate, voiding on the floor and throwing feces, and was 
transferred to a psychiatric ward. Her delirium resolved over 48 hours with psychiatric 
treatment, and she was discharged from the hospital on day 35 (Choi, 1998). 
 
Racemic Isomalathion.  Commercial malathion is supplied as a racemic (RS) mixture of 
the R and S forms arising from an asymmetric carbon in its diethyl thiosuccinate group. 
The corresponding steroisomers of malaoxon differ 8.6-fold in their inhibitory potencies 
against rat brain AChE. Thermal or photochemical isomerization may occur during 
storage of racemic malathion to yield racemic isomalathion, which is 1000-fold more 
potent than the parent compound. 
 
Shelf storage of malathion at 38C increases both its isomalathion content and its toxicity. 
For example, unusually high levels of isomalathion were linked to 2800 poisonings 
including 5 fatalities among 7500 Pakistani spraymen using malathion for malaria control 
(Baker, 1978). Contamination of malathion by isomalathion acts synergistically to 
increase toxicity by inhibiting the detoxification potential of liver carboxylesterase 
enzymes.  
 
Isomalathion contains two asymmetric centers, one at phosphorus, and the other at the 
carbon in the diethyl thiosuccinate moiety, yielding four stereoisomers. Inhibitory 
potencies of these isomers against AChE differ by as much as 29-fold. Individual 
stereoisomers each form Michaelis complexes with this enzyme prior to the expulsion of 
the primary leaving group and organophosphorylation of the active site serine. 
Subsequently, the inhibited enzyme could undergo either reactivation (displacement of 
the entire organophosphoryl group) or aging (scission of a ligand from the inhibitor, 
leaving a negatively charged organophosphoryl group).   
 
Aging to yield a negative charge in the active site leaves the enzyme intractable toward 
reactivation. Diethyl thiosuccinate is the primary leaving group for R-isomalathion, while 
thiomethyl is the primary leaving group for S-isomalathion. This unexpected 
stereochemically determined switch in the inhibition mechanism potentially extends the 
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range of toxicological consequences arising from exposures to the isomalathions. Aging 
of both electric eel AChE and equine seurm butyrylcholinesterase (EBChE) by S-
malathion via an SN2 reaction with P-S bond cleavage to yield an O-methyl phosphate 
adduct has recently been reconfirmed (Doorn, 2001). 
 
Apart from cholinergic toxicity elicited by AChE inhibition, some organophosphate 
compounds inhibit and age >70% NTE, producing the OPIDN syndrome. Certain 
structural requirements have been elucidated for organophosphate inhibitors of NTE. For 
a given primary leaving group, longer-chain dialkyl ligands on phosphorus are preferred 
over dimethyl or diethyl analogs, and small leaving groups are favored among longer-
chain dialkyl-substituted organophosphates. Considering these structure activity 
relationships, malaoxon isomers and the isomalathions would be expected to be poor 
inhibitors of NTE if diethyl thiosuccinate were the primary leaving group. However, if 
thiomethyl were the primary leaving group, as found in the S-isomalathion configuration, 
then inhibition of NTE would appear to be a reasonable possibility.  
 
In view of unexplained reports of neuropathic sequelae associated with malathion 
intoxication in humans, and the fact that isomalathions can arise as impurities in 
malathion preparations, and the fact that isomalathions are potent inhibitors of esterases 
other than NTE, the possibility exists that these compounds could be potentiators, rather 
than initiators, of neuropathic processes (Healy, 1959) (Harell, 1978) (Rivett, 1987) 
(Komori, 1991) (Jianmongkol, 1996).   
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Chapter Two 
 
Skin Absorption 
 
Introduction.  Interest in skin permeability arises mainly from the capacity of the skin to 
limit the body’s accumulation or elimination of substances by percutaneous transport.  
Although a complex process, dermal uptake of compounds occurs mainly through passive 
diffusion, involving a selective mechanism in the lipid and protein structures of the 
stratum corneum. This epidermal skin barrier is the major factor in this process and can 
reduce overall rates of accumulation by several orders of magnitude. For example, water-
soluble, low molecular weight, non-electrolytes can diffuse into the bloodstream 1000 
times more rapidly if the epidermis is diseased, damaged, or removed. Even with the skin 
intact, there are still 10,000 fold differences in the rates of penetration of different 
substances. 
 
Stratum Corneum.  The principal barrier function of the epidermis resides almost entirely 
in the stratum corneum, the thin coherent membrane of keratinized, epithelial cells that 
comprise the “dead” surface layer of the epidermis. The phenomenon of percutaneous 
absorption is essentially one of adsorption onto the stratum corneum (10 um thickness), 
diffusion through it and through the viable epidermis (100 um thickness), and finally 
through the papillary dermis (100-200 um thickness) and into the microcirculation. 
 
The composite skin layer is pierced by two types of diffusion shunts: hair follicles and 
sweat glands. Sebaceous glands are attached to follicular walls at distances of 500 um 
below the surface, and for this reason their effectiveness as shunts is probably negligible. 
Hair follicles (40-70/cm2) and sweat glands (200-250/cm2) do act as diffusion shunts, 
but their role is more subtle than one might think. Although the fractional area covered by 
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these appendages is only 0.1%, diffusion constants of low-molecular weight molecules 
moving through the appendages are greater than through stratum corneum. Before steady-
state diffusion is established, and particularly during the first few minutes after the 
application of a substance, the follicles and ducts cannot always be ignored even when 
the ultimate steady-state flux through these shunts is small.     
 
The slow rate of malathion dermal absorption and its efficient rate of elimination reduces 
the risk of acute toxicity for all exposures except when involving substantial portions of 
unprotected skin. Water as a common vehicle may play an important role in increasing 
the permeability of malathion in the stratum corneum. If penetrants are easily dissolved in 
their oil vehicles applied to the skin, penetration is more difficult. For example, carbon 
disulfide and analine are absorbed through the skin about 100 times faster from aqueous 
solutions compared with oil solutions. The comparatively high rate of skin absorption of 
compounds from their aqueous solutions seems to be a rule that could be related to the 
hydration of stratum corneum (Scheuplein, 1965) (Baranowska-Dutkiewicz, 1982). If the 
skin is hydrated, or the compound is in solution, diffusion and penetration will be 
enhanced. On the other hand, stratum corneum may be subject to compaction and 
dehydration when in contact with pure solvents. In addition, the necrotizing effects of 
concentrated solvents in contact with skin act to limit absorption. Such data indicate that 
skin absorption rates from dilute aqueous solutions may be seriously underestimated. 
 
The entire skin and not just the stratum corneum can interact in important ways with 
solvent mixtures. One might conceptualize percutaneous absorption as a process of 
diffusion through the stratum corneum, followed by systemic uptake at the epidermal-
dermal junction. Furthermore, evaporation from the skin surface, reservoir formation in 
the dermis, and percutaneous penetration are interrelated processes that are important in 
determining the fate of topically applied compounds. Rapid penetration into the dermis 
may occur with pesticides even after attempted soap and water decontamination 
(Reifenrath, 1991). 
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Intercellular spaces in the stratum corneum are normally filled and mechanically 
coherent. The conversion of aqueous epidermal cells into dried, compact, keratin-
containing stratum corneum cells is the crucial event in the continuously developing 
epidermis that largely determines the low permeability of skin. The viable skin tissue 
layers and the capillaries are relatively permeable, and the peripheral circulation 
sufficiently rapid so that for the great majority of substances diffusion through the 
stratum corneum itself is rate limiting. The usual diffusion laws of physics pertaining to 
passive diffusion processes can therefore be applied to skin permeability phenomena and 
greatly aid in its description. 
 
The rate-limiting barrier within the stratum corneum is typically the hydrated intercellular 
keratin. This keratin has an affinity for both water-soluble and lipid-soluble compounds. 
Keratin’s bi-functional solubility arises from its inherently mosaic, filament-matrix ultra-
structure which allows aqueous and lipid regions to exist separately. For this reason, 
attempts to predict permeability constants from correlations with oil-water partition 
coefficients (Kow) have proved only marginally successful. For larger molecules and 
molecules with several polar groups, the relative importance of the stratum corneum 
increases still further (Scheuplein, 1971).   
 
Fick’s Law.  Many investigators have reported on the toxicity and unexpectedly high 
penetration rates of volatile organic compounds. Through relatively simple analysis of 
absorption from specific compounds, it is possible to estimate potential absorption using 
Fick’s Law. Dose may then be calculated using experimentally-derived skin absorption 
rates and constants (Kp). Fick’s Law essentially describes the behavior of dilute aqueous 
solutions, such that absorption of the solute will be directly proportional to concentration. 
In more detail, Fick’s Law may be used to determine the permeation rate of solvents in an 
aqueous solution, and is expressed by the formula:  
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Js = Kp * ∆C 
 
Where: 
Js = permeation rate (flux) of the solute expressed as mcg/cm2; 
Kp = permeability constant expressed as liters / cm2 / hr; 
∆C = concentration difference of the solute across the specified tissue in mcg/L. 
 
For example, using Fick’s Law, permeability constants for the following compounds in 
weak aqueous solutions were experimentally derived: 
 
Table 3: Reference Permeability Constants (Kp). 
Compound  Aqueous Solution  Permeability Constant 
   Concentration: (mg/L) Kp (L / cm2 / hr) 
Ethylbenzene        112   .00100 
Toluene       180    .00090 
Styrene         66    .00060 
Carbon Disulfide   1000    .00050  
Trichloroethylene     100    .00020 
Chloroform          0.5   .00012  
Aniline   10000    .00004 
(Dutkiewicz and Tyras, 1967, 1968). 
 
Skin absorption rates are typically derived from experimental situations where the hands 
and wrists are immersed in test solution. Rates obtained in this manner, however, will 
underestimate actual absorption in cases of whole-body immersion during swimming. 
The epidermis of the hand represents a relatively greater barrier to penetration than many 
other parts of the body, especially hair-follicle-rich areas. For example, the scrotum has 
an imperfect stratum corneum because of the enormous demands made on it in terms of 
flexibility, and is well known to absorb almost all of several pesticides. In addition, the 
face, forehead, scalp and neck absorb 2-6 times more than the forearm. Hands and feet 
absorb about as much as the forearm, but absorption is slower. Larger areas of the body, 
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such as the back, allow greater absorption than the forearm (Feldmann and Maibach, 
1974). 
 
Table 4: Malathion Anatomical Dermal Absorption Rates and Ratios in Humans. 
   Ratio  Rate: %Dose Recovered in Urine at 0-5 days 
Palm     0.9 
Forearm    1.0    6.8 ±   2.3% 
Foot     1.0    6.8 ±   3.2% 
Abdomen    1.4    9.4 ±   7.9% 
Hand, Dorsum    1.8  12.5 ±   4.0% 
Hand, Palm      5.8 ±   2.9% 
Scalp     3.7 
Jaw Angle    3.9 
Forehead    3.4  23.2 ±   9.1% 
Ear      4.0 
Axilla     4.2  28.7 ± 13.7% 
Scrotum   11.8 
Malathion concentration at 4 mcg/cm2 in a non-occlusive acetone vehicle. 
Subjects requested not to wash the site of application for 24 hours. 
(Maibach, 1971). 
 
Quick reference to a Lund and Browder Chart shows that forearm and hand surface area 
compared to total body surface area is 11:100, or Fs = 0.11. Adjusting this figure for 
Maibach’s relative absorption characteristics in different body surface areas yields an 
adjusted factor of 11:142, or Fsadj = .0775.   
 
  
26 
Table 5: Body Surface Area by Relative Absorption. 
 
Anatomic   Surface  Relative   Multiplication 
Location   Area   Absorption  Factor 
Head       7%     3.7     25.9  
Neck       2%     2.0 (est)      4 
Ant Trunk    13%     1.4        8.9 
Post Trunk    13%     1.4 (est)      8.9 
Buttocks      5%     1.0 (est) `     5 
Genitalia      1%   11.8     11.8 
Both Upper Arm     8%     1.0 (est)      8 
Both Lower Arm     6%     1.0       6 
Both Hands      5%     1.0       5 
Both Thighs    19%     1.0 (est)    19  
Both Lower Legs   14%     1.0 (est)     14  
Both Feet      7%     1.0       7 
Total    100%      142.1 
(Brown, 1984). 
 
Rate of Absorption.  The entire skin, not just the stratum corneum or epidermis, can 
interact in important ways with topically applied compounds. Evaporation from the skin 
surface, reservoir formation in the dermis, and percutaneous penetration are interrelated 
processes that are important in determining the fate of topically applied compounds. 
Rapid penetration into the dermis may occur with organophosphates and may account for 
percutaneous absorption even after one minute of decontamination with soap and water. 
(Reifenrath, 1991). 
 
Percutaneous penetration rates are determined by the physiochemical properties of a 
compound such as molecular weight, solubility, charge distribution, partition coefficients, 
and various other parameters. Correlations are consistent for compounds having closely 
related chemical structures. However, meaningful results are often inconsistent where 
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chemicals of diverse structure are compared. The rate of dermal uptake of malathion 
compared to other insecticides was assessed in a shaven mouse skin model (upper 
shoulder). As shown in Table 6, and compared to the 13 other insecticides investigated, 
malathion exhibited the longest half-life and the least penetration.  
 
Table 6: Pesticide Rates of Dermal Absorption in Mice. 
Compound: Half-life: Penetration: Excretory GI  Carcass  
    1 hr  8 hr 8 hr  8 hr  8 hr 
Carbaryl   13 min 72% 88% 73%    8%     6%  
Chlordecone   41 min 54% 66%   4%  20%   25%  
Parathion   66 min 32% 85% 50%  10%   17% 
Dieldrin   72 min 34% 83%   4%  12%   62% 
DDT  105 min 34% 71%   4%  15%  41% 
Malathion 130 min 25% 67% 30% (urine)   2%   33% 
Penetration is disappearance of radioactivity from 4 cm2 shaved skin, upper shoulder. 
(Shah, 1981).   
 
It is notable that malathion dermal penetration rates are quite variable in nature among 
different mammalian species. In Yorkshire swine, after non-occlusive malathion 
application to the ventral abdominal skin, corrected systemic absorption was only 5% at 6 
days. Systemic absorption for malathion as a percentage of the original dermal dosage 
was less than all other compounds tested (benzoic acid > progesterone > caffeine > 
testosterone > parathion > malathion) in Yorkshire swine (Carver, 1989). In rats, after 
non-occlusive malathion application to 10 cm2 shaven dorsal back for 8 hours, 
autoradiograms demonstrated 28% of the dose concentrated at the application site, 29% 
in the skin at large, and 23% contained in the urinary bladder (Saleh, 1997).  
 
Complex mathematical models for the dermal absorption of a dilute malathion solution in 
humans are available. A physiologically-based pharmacokinetic (PBPK) model has been 
created that utilizes tissue volume compartments, air and blood flows, and chemical-
specific partition coefficients. PBPK incorporates seven body compartments (skin 
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surface, skin perfused, fat, muscle, kidney-vessel rich group, intestine, and liver) and four 
external compartments (air, urine, feces, and acid metabolites). Skin evaporation and 
oxidative metabolism of malathion to malaoxon are incorporated into this model as well. 
This adult PBPK model, which notably assumes Kp-malathion = 0.001 L/cm2/hr, predicts 
during total immersion scenarios that 7-31% of the applied dose will be systemically 
absorbed. Furthermore, 70% of that systemically absorbed dose is metabolized and 
excreted within 24 hours (Kizer, 1991). 
 
PBPK rate constants were chosen to approximate experimental data. The model’s skin 
permeability constant (Kp = 1 x 10-5 /min to 5x10-4 /min, skin surface to viable epidermis) 
was less than the skin evaporation constant (Kevap = 8 x 10-5 /min to 5 x 10-4 /min, skin 
surface to air)). This important ratio, Kp/Kevap≤1, was based upon several classic studies. 
Maibach demonstrated in three studies that 4%, 8%, and 7% of [C14]-malathion applied 
to human forearm skin was excreted in 0-7 day urine samples. Peak excretion was 8 
hours post-application. As shown in Table 4, up to 29% urinary recovery came from 
more absorptive (but smaller surface area) parts of the body (Webster and Maibach, 
1983) (Feldmann and Maibach, 1974) (Maibach, 1971). Increasing air flow over the 
surface of excised pig skin undoubtedly increases evaporative loss for malathion. 
Significant evaporative loss for malathion occurred from both the skin surface-epidermis 
layer and the dermis layer. In fact, increased air flow decreased malathion dermal 
residues but not parathion, DDT, nor DEET dermal residues. Penetration of the applied 
malathion dose at 48 hours in the excised pig skin model decreased from 21% to 9% as 
air flow was increased from 60 to 600 ml/min (Reifenrath, 1991).     
 
Total Immersion.  Swimming pool and bathing immersion models show that skin 
absorption represents a significant route of exposure. In fact, dermal absorption can 
contribute from 29-91% of the total daily dose, for an average contribution of 64%. This 
information suggests that when doses from dilute aqueous solutions are calculated 
through Fick’s Law, and carefully considered, margins of safety may be significantly 
more narrow than anticipated. On this basis, regulatory guidelines and policies may need 
to be reconsidered (Brown, 1984). 
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In another swimming pool exposure model, chlorinated pools were found to contain an 
average of 156-500 mcg/L (156-500 ppb) chloroform contamination. A worst case 
dermal exposure model was built utilizing Fick’s Law kinetics. Swimmers were assumed 
to be totally immersed for three hours daily. During immersion, some absorption of the 
aqueous chloroform was presumed to occur through the dermal and aural routes. 
Accelerated dermal absorption would be expected from skin that has been freshly 
wounded, abraded or sunburned. During some of the time the swimmer was immersed, 
the internal tissues of the nose, mouth and eyes would also be exposed. For example, 
about five milliliters of water is taken into the mouth and squirted out with each breath 
when a child swims. In summary, dermal absorption from the dilute aqueous solution 
represented 60% of the dose, as shown in the table below:  
 
Table 7: Skin Absorption Rates of Chloroform in 500 ppb Aqueous Solution. 
Route    Relative Absorption 
Dermal    60% 
Oral          3% 
Buccal / Sublingual      3% 
Orbital / Nasal       3% 
Aural       3% 
Inhalation    28% 
(Beech, 1980). 
 
An improved methodology to predict in vivo Kp values for dilute aqueous solutions 
based upon molecular weight and oil-water partition coefficients was recently derived by 
(Bogen, 1994) as follows:  
Log10Kp  =         -0.812 – 0.0104 * MW + 0.616 * log10Kow               cm/hr 
Kp   = (10^(-0.812 – 0.0104 * MW + 0.616 * log10Kow)) / 1000         L/cm2/hr 
Kp Toluene  = (-0.812 – 0.0104 * 92.1 + 0.616 * 2.73) / 1000  = .0008200  L/cm2/hr  
Kp Chloroform  = (-0.812 – 0.0104 * 119.4 + 0.616 * 1.97) / 1000  = .0001400  L/cm2/hr  
Kp Parathion  = (-0.812 – 0.0104 * 291.3 + 0.616 * 3.83) / 1000  = .0000300  L/cm2/hr  
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Kp Chlorpyrifos  = (-0.812 – 0.0104 * 350.62 + 0.616 * 4.70) / 1000  = .0000300  L/cm2/hr  
Kp Malathion  = (-0.812 – 0.0104 * 330.36 + 0.616 * 2.75) / 1000  = .0000030  L/cm2/hr  
Kp Malaoxon  = (-0.812 – 0.0104 * 314.36 + 0.616 * 2.02) / 1000  = .0000015  L/cm2/hr  
 
Vertebrate Models.  Vertebrate behavioral studies after exposure to dilute malathion 
solutions are effective indicators of contamination and reflect sub-lethal toxicity. Because 
behavior is an integrated result of endogenous and exogenous processes, behavioral 
studies provide a way to address the question of effect in contaminant work. When using 
fish as a bio-indicator, it has been suggested that a stressful condition is detected when 
one or more physiological variables are altered to the point where long-term survival may 
be impaired. Swimming behavior in fish is frequently assessed as a response in toxicity 
investigations because altered locomotor activity can indicate effects to the nervous 
system.  
 
Fish were exposed to 20-50 mcg/L (20-50 ppb) dilute aqueous malathion solutions for 24 
hours. Malathion exposure caused dramatic decreases in distance swam and swimming 
speed as well as pronounced changes in complexity of swimming paths. A highly positive 
correlation was found between 26% decreased brain cholinesterase activity and decreased 
swimming speed. Significant fish mortality was found when the dilute aqueous malathion 
solution concentration was increased to an 50 ppb exposure level and as a result caused 
50% brain acetylcholinesterase inhibition (Cook 1976) (Brewer, 2001).         
 
The sensitivity of vertebrate brain cholinesterase to malaoxon is as follows: sculpin fish > 
chicken > sparrow > flounder > sunfish > bass > rat > mouse > monkey > duck > 
bullhead > guinea pig. In summary, as far as brain cholinesterase sensitivity is concerned, 
there is no clear grouping according to vertebrate class. However, sensitivity to poisoning 
by malathion is as follows: fish > chickens > mice. Mouse liver hydrolyzes more than ten 
times as much malathion as sunfish liver and about three times as much as chicken liver. 
Therefore, the greater susceptibility of fish to poisoning by malathion can best be 
accounted for on the basis of their relative inability to detoxify malaoxon (Murphy, 
1968).
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Chapter Three 
 
Medfly Eradication Exposure Data 
 
Background.  Certain malathion formulations are registered by EPA for aerial spraying 
over urban areas in mosquito-control programs. The use of malathion in these programs 
provides an important public health benefit by controlling mosquitoes that transmit 
human disease (e.g. encephalitis, dengue fever, malaria). However, the spraying of 
malathion bait over urban populations for Medfly eradication has generated controversy 
in part because these applications are directed not at preventing human illness but at 
eradicating an agricultural pest. 
 
Federal law does not permit spraying malathion bait over urban areas without an 
emergency EPA exemption. If and when the EPA grants said exemption, the responsible 
government authorities post advance notification of spray schedules, schedule malathion 
spraying episodes at night, and advise the public to stay indoors during spraying events 
and wash any skin surface that may contact the malathion bait (Shafey 1999). 
 
Aerial malathion bait may be used as a regulatory control method to establish freedom of 
nursery or orchard premises from living fruit fly stages, as a condition for movement of 
produce. To accomplish this, the establishment undergoes a series of treatments at 
intervals, designed to provide continued freedom from fruit flies during the quarantine 
period. Bait spray applications normally are limited to locations producing regulated 
commodities within a quarantined area, but located outside the infested core area. 
Treatments must start at a sufficient time, at least 30 days, before harvest (to span the 
interval that normally would include the completion of egg, larval, and pupal 
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development), then continue throughout the harvest period. The required pre-harvest 
treatment makes this option useful for only those commodities remaining in the field for 
more than 30 days after an area is quarantined (Smith, 2001). 
 
Full foliar coverage bait spray of host trees and other plants immediately reduces fruit fly 
populations by 90 percent or more and reduces subsequent reproduction. This decreases 
fruit fly numbers in the succeeding generation and reduces the risk that gravid female 
fruit flies will move to uninfested areas. In this manner, the malathion bait applications 
reduce wild fruit fly populations to a level of infestation where mating thresholds are not 
achieved or where continued releases of sterile fruit flies can be effective in reducing the 
rest of the emerging pest population. 
 
Technical Malathion.  Numerous compounds are found in technical grade formulations of 
pesticides. These co-products occur from breakdown or conversion of the active 
ingredient, and from unintentional reactions occurring during pesticide synthesis.  
 
Isomalathion is one of the largest potentiators of malathion toxicity, and is equipotent to 
malaoxon. The in vivo mechanism of potentiation is inhibition of B-type 
carboxylesterases (CEBs), the group of liver enzymes responsible for the metabolism of 
malathion and malaoxon into their non-toxic alpha and beta monacids. Technical 
malathion mixtures stored for extended periods of time under warm, humid conditions 
may contain isomalathion at concentrations as high as 7%. Each one percent increase in 
isomalathion content increases mammalian toxicity by an order of magnitude (Baker, 
1978). 
 
The concentration of technical malathion co-products varies from batch to batch, but the 
major co-products are typically as shown in the following table.  
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Table 8: Technical Malathion. 
• Isomalathion      0.20% 
• Malaoxon      0.10% 
• Diethyl fumarate     0.90% 
• O,O,S-trimethyl phosphorothioate [OOS(O) ] 0.04% 
• Diethyl methylthiosuccinate    1.00% 
 
Concentrations of isomalathion in technical mixtures are generally quite low, rarely 
exceeding 0.5% of the nominal malathion content. This conversion to isomalathion is 
most prone to occur in water dispersible powders, where levels exceeding 3.0% are 
common. Isomerization is a function of storage temperature, relative humidity, and 
storage time. Increasing relative humidity from 41 to 65% increased the conversion rate, 
as did storage for six months at 40C. The World Health Organization recommends that 
technical malathion mixtures exceeding 1.8% isomalathion be discarded and not used.  
 
Trimethyl phosphorothioates [OOS(O)] are present as impurities, reaction products and 
breakdown products in technical grade malathion. OOS(O) is known as a potent inhibitor 
of cholinesterases, beta-carboxylesterases, and neuropathy target esterases, especially 
when reaching concentrations of 0.2-1.0% in the technical grade malathion mixture.     
 
Diethyl fumarate is known as the causative agent of non-immunologic contact urticaria 
(NICU) in humans. Skin irritation and rashes have been reported following malathion-
bait applications, both of which are symptomatic of NICU.   
 
(Kizer, 1991).      
 
Environmental Fate.  Most organophosphate insecticides are used for crop spraying in 
commercial agriculture. Approximately 75% of all insecticides are used for cotton, corn 
and soybeans. Malathion is the most widely used organophosphate insecticide. 
Organophosphate compounds degrade in the environment at varying rates: half-lives 
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range from days to months, although generally half-lives are longest in dry climates and 
low temperature.   
 
Soil.  Malathion is of low persistence in soil with field half lives of up to 25 days. 
Degradation in soil is rapid and related to the degree of soil binding. Breakdown occurs 
by a combination of biological degradation and non-biological reaction with water. If 
released to the atmosphere, malathion will breakdown rapidly in sunlight, with a reported 
half-life in air of about 1.5 days. It is moderately bound to soils, and is soluble in water, 
so it may pose a risk of groundwater or surface water contamination in situations which 
may be less conducive to breakdown.  
 
Water.  Malathion when dissolved in bodies of water is readily oxidized to malaoxon by a 
variety of mild oxidizing reagents. Thus, it is generally recognized that malathion is 
easily oxidized to malaoxon by swimming pool chlorine concentrations. For example, 
malaoxon has greatest persistence when pool water is acidic, and malathion is stable in 
oxygen saturated water at acidic pH for up to two weeks. Sunlight shortens malathion and 
malaoxon half-lives in pools to 3 days. These data suggest that little accumulation of 
malathion or malaoxon in swimming pools occurs, but does indicate that they can persist 
at low levels for a considerable period of time.  
 
In river water, the half-life of malathion is generally less than one week. For example, in 
the Suwanee River with large amounts of tannins, malathion was 50% degraded by 
sunlight within 16 hours. However, malathion may remain stable in distilled water for 
three weeks and its photolysis half-life is 41 days. Applied at up to 6 pounds per acre in 
log ponds for mosquito control, it is generally effective for 2.5-6 weeks. In seawater, 
degradation increases with salinity. Breakdown products in acidic water are mono- and 
dicarboxylic acids such as dimethyl phophorothionic acid and 2-mercaptodiethyl 
succinate (Howard, 1991) (Wolfe, 1975). 
 
Hydrolysis of malathion in basic pH aqueous solution yields primary breakdown products 
diethyl fumarate and dimethyl phophorodithioic acid (DMPTA). At pH 8.0, diethyl 
  
35 
fumarate remains stable for 1.5-4 days. In the fathead minnow animal model, two-way 
and three-way interactions of the breakdown products caused large synergistic increases 
in toxicity. In particular, diethyl fumarate could be produced as a breakdown product in 
significant quantities in basic pH aqueous solutions to produce synergistic toxic effects 
with malathion in vivo (Cook, 1976). 
 
Air.  Malathion bait is oxidized rapidly in the atmosphere by ozone and dinitrogen 
tetraoxide to malaoxon, but not by molecular oxygen. Thus, two days post-spray 
application the outdoor air concentration of malaoxon generally exceeds that of 
malathion. Air concentrations of malathion also increase at two days post-spray 
application by volatilization of the bait droplets.  Outdoor particle diameter is ~100 um 
with particles ranging up to 350 um. Indoor particle diameter is ~3 um and lower, evenly 
distributed on walls, ceilings and floors. Malathion bait found indoors is 3% of the 
amount found in the adjacent outdoor area (Caplan PE, 1956) (Kizer, 1991).    
 
Hillsborough County, Florida, 1997.  Medfly eradication commenced via aerial 
malathion protein bait application on June 5, 1997. About 2.4 ounces by weight of 
malathion with 9.6 ounces of corn syrup protein bait was targeted to each acre in the 
quarantine area. About 2.6 mg/ft2 of malathion was targeted into nine square mile areas 
centered around each Medfly find. During the ten week time period under study, thru 
August 1997, vintage military aircraft sprayed 31,000+ gallons of malathion bait over 
400+ square miles of Hillsborough County landscape. One million people lived and 
worked in the aerial spray zone areas (Smith, 2001). 
 
This malathion bait concentration transferring from the air into a one meter deep body of 
water typically yields a 22 ppb dilute aqueous solution. Importantly, however, bait spray 
applications are made at 5-10 day intervals until eradication is achieved. Certain areas in 
Lakeland, for example, were sprayed at least 8 times. As a result, large fluctuations in 
concentration are known to have occurred in “Medfly hot zones”, DC-3 flight pattern 
overlapping zones, and bodies of water subject to storm-water runoff.  
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A registry for people reporting increased health problems associated with the malathion 
spray program was established. The “Malathion Health Survey” is a cooperative effort 
between the USF College of Public Health, Poison Control Center, and Hillsborough 
County Health Department. As of 10/6/97, more than 700 calls from people reporting 
exposure to malathion had been received.  Most reported some kind of symptoms, 
including nausea and headaches. 
 
The Tampa Tribune has featured possible victims with adverse reactions temporally 
related to the application of malathion bait: 
(1) A 7yo diver and swimmer had 3 days of headache, nausea and sore throat when 
practicing the day after a DC-3 sprayed malathion in and around Brandon Swim 
and Tennis Club (BSTC) pool. The swimming pool was found the day after 
spraying to have 12 ppb malaoxon contamination; 
(2) An elementary school teacher sprayed with malathion on campus had a rash; 
(3) A restaurant worker caught in the path of a DC-3 had nausea and chest pain; 
(4) Three children had blisters/rashes on shoulders/arms and diarrhea after playing in 
a Riverview lime tree the day after malathion spraying; 
(5) A man’s arm had angry red rash when immersed in family pool 3 hours after 
malathion spraying.  
 
Only limited environmental sampling has been accomplished during the aerial application 
of malathion spray in Hillsborough County.  The Environmental Protection Commission 
(EPC) of Hillsborough County has published a limited number of water sample results as 
follows: 
 
Table 9: Tampa Swimming pool sampling by FL-EPC (ppb). 
• Malathion- range 0- 1;  mean 0. 
• Malaoxon- range 1-19;  mean 5. 
• Malaoxon at BSTC on Day 0=24 ppb; Day 1=12ppb; Day 2=5ppb; Day 3=2.5ppb. 
• BSTC Swim and Diving Team (n=15-20): 33-50% became ill when swimming the 
day after aerial application of malathion bait to the swimming pool area. 
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Table 10: Tampa Pond sampling by FL-EPC (ppb). 
• Malathion- range 21-79;  mean 49. 
• Malaoxon- range 00-01;  mean 01. 
• Malathion city water treatment plant = 0.7, and malaoxon = 0.5. 
• Malathion at Riverview apartment pond = 25. 
• Malathion at Alafia River = 12. 
• Malathion at six fish kill sites = 2.3-25.0. 
 
Dade, Lake, Marion, Manatee and Highland County, Florida, 1998.  During the spring 
and summer of 1998, aerial malathion and ground diazinon application was used by 
federal and state agriculture authorities to eradicate Medfly infestations that had been 
detected in portions of five Florida counties. All insecticide application was complete on 
September 6 with an estimated 132,000 persons residing in the pesticide treatment area.  
 
Reports of potential adverse health effects attributed to the Medfly Eradication Program 
were solicited by state health and agriculture authorities. During the Spring and Summer 
months, 230 reports of illness were investigated and classified by the Florida Department 
of Health as outlined in the following table.  
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Table 11: Medfly Spray-related Adverse Events, Florida Department of Health.  
• Probable: 34 (15%), based upon abnormal medical signs observed by a licensed 
health-care professional; 
• Possible: 89 (39%), based upon abnormal symptoms compatible with 
organophosphate toxicity reported to health-care workers or a state health 
authority. 
• Probable plus Possible: 123 (54%), or crude incidence rate of 9 / 10,000 residents; 
• Eight reports involved children < 5yo; 
• Twenty reports involved elderly > 65yo; 
• Four reports involved work-related illnesses such as pesticide applicators; 
Of the signs and symptoms reported in the “Probable plus Possible” group: 
• 71% were respiratory (dyspnea, wheezing, coughing); 
• 63% were gastrointestinal (cramping, nausea, vomiting, diarrhea); 
• 60% were neurologic (headache, vertigo, ataxia, paresthesia, confusion); 
• 23% were dermatologic (erythema, rash, pruritis); 
• 23% were ophthalmic (lacrimation, conjunctivitis, blurred vision). 
In the case reports, specific exposures were reported while: 
• Conducting lawn maintenance business, where grass trimmings stuck to skin; 
• Working on roof of house; 
• Removing pool cover, which was folded and carried under sleeveless arm. 
(Shafey, 1999). 
 
Los Angeles, California, 1990.  In California, more extensive environmental sampling has 
shown the amount of malathion bait actually sprayed on some occasions was 40-350% 
more than would be predicted from uniform coverage calculations:   
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Table 12: Los Angeles Swimming pool sampling by CA-EPA (ppb). 
• Malathion- range 4-90;  mean 18. 
• Malaoxon- range 0-46;  mean 16. 
• Malaoxon was found in two pools one week after application at 7 ppb. 
 
Table 13: Los Angeles Pond sampling by CA-EPA (ppb). 
• Malathion- range 21-79;  mean 49. 
• Malaoxon- range 00-01;  mean 01. 
 
Table 14: Los Angeles Storm-water runoff by CA-EPA (ppb). 
• Malathion- range 0-703;  mean 151. 
• Malaoxon- range 0- 18;  mean    2. 
 
In summary, there is solid evidence for potential toxic exposure to malathion and its co-
products while swimming in outdoor bodies of water during and after aerial malathion 
bait application.  Furthermore, Los Angeles County exposure data has found swimming 
malathion pool contamination as high as 90 ppb. Many malathion bait spray scenarios 
may converge to account for high environmental concentrations: e.g. physical-chemical-
biological reactions; over-lapping spray areas; repeat spray areas, human error; technical 
limitations; and weather fluctuations.    
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Chapter Four 
 
Hazard Index 
 
The aerial application of malathion bait results in exposure by three routes: inhalation, 
ingestion, and dermal absorption. Exposure may be acute, sub-acute, or chronic in nature.  
Exposure to malathion and/or its three significant co-products, isomalathion, malaoxon, 
and diethyl fumarate, may occur depending upon the specific scenario under study. The 
scope of this analysis will focus only upon an adult and child’s acute dermal exposure to 
dilute aqueous concentrations of malathion and one of its co-products, malaoxon, while 
immersed in a contaminated swimming pool after a typical aerial malathion bait spray 
episode. 
 
In presenting exposure and dosage scenarios, the concept of reference exposure level 
(REL) is utilized: the level at which no adverse health effects are anticipated.  Therefore, 
health protection is achieved if the estimated dosage is below the relevant REL.  In order 
to make REL data easier to interpret, a Hazard Index (HI) format is chosen, where HI = 
(estimated dosage / REL).  Note that hazard index > 1 represents possible exposure 
scenarios greater than the relevant REL. Estimated dosages > REL or hazard indexes > 1 
are not necessarily hazardous, and do not absolutely result in significant health effects; 
however, further analysis may be warranted.  
 
Several independent studies and guidelines are available to define the “incipient toxicity” 
level for malathion exposure. In the best available study, depression of cholinesterase 
activity was observed two weeks after the oral administration of malathion 24 mg to five 
human subjects for 55 consecutive days.  Maximum depression of plasma cholinesterase 
activity (25%) and red blood cell (RBC) cholinesterase activity (30%) occurred three 
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weeks after cessation of malathion. In spite of the depression in both plasma and RBC 
cholinesterase activity, no clinical side effects were observed. In summary, this report 
agrees with the State of CA assessment of about 0.2 mg/kg/day as the preliminary REL.  
 
The best available approach for estimating dermal exposure to malathion in a swimming 
pool is the model utilized for chloroform (CF) and trichloroethylene (TCE) for baths and 
showers. This type model is specific for dilute aqueous solutions of lipophilic, organic 
contaminants. 
 
In vitro and in vivo measurements of CF and TCE uptake by human skin from dilute 
aqueous solution indicate that short-term, non-steady-state, dermal uptake kinetics are 
consistent with a first-order partition model. The first-order partition coefficient 
estimation assumes that the stratum corneum is the effective skin compartment volume of 
distribution, as it likely is with most lipophilic, organic compounds such as malathion.  
 
Blood perfusion to skin is likely to cause relatively rapid equilibrium of chemical 
concentrations within the epidermis, and perhaps within the underlying dermal tissue as 
well. This scenario is expected particularly in the shower, bath and swimming pool 
scenarios, involving relatively high water temperatures known to elicit a ten fold increase 
in local dermal blood perfusion rates (Bogen, 1995). 
 
For example, Bogen’s method can be utilized, with some key assumptions, to derive an 
exposure estimate for a child in a contaminated swimming pool model as follows: 
 
Ds = Kp*Dc*De*Fs*As*Sys / Mb 
 
Where: 
 
• Ds = systemic dose rate in mg/kg/day 
 
And: 
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• Kp-malathion  = permeability constant across the skin = 0.001 L/cm2/hr; 
• Dc = concentration of malathion in water  = 30 mcg/L or 30 ppb;  
• De = duration of contact with contaminated water = 3 hr; 
• Fs = fraction of skin in contact with water  = 1.0; 
• As = exposed skin surface area   = 12 000 cm2; 
• Mb = body mass     = 34.5 kg; 
• Sys = Dermal absorption to Systemic Absorption = 0.10. 
 
The dermal absorption to systemic absorption conversion factor (Sys = 0.10) is an 
important parameter that deserves further explanation. This factor is derived from 
Maibach’s three human studies of non-occlusive, concentrated dermal malathion 
absorption versus Dary’s contrasting occlusive study of human forearms utilizing dilute 
malathion aqueous solution exposures (Webster and Maibach, 1983) (Feldmann and 
Maibach, 1974) (Maibach, 1971) (Dary, 1994). Dary determined that 15% of the initial 
applied dose is systemically absorbed and eliminated in urine, but this figure may be 
adjusted downward towards Maibach’s figures (4%, 8%, and 7%) to account for the non-
occlusive setting of the swimmer. That is, it is assumed that swimmers first shower with 
soap and water after three hours of swimming, in effect mechanically removing 
malathion from the skin surface-epidermis layer, then secondly move into environmental 
settings conducive to dermal layer evaporation over the remainder of the day.  
 
Assuming Kp-malathion is reasonably estimated from similar Fick’s Law studies of 
ethylbenzene, toluene, styrene, and xylene in dilute aqueous solutions, the specific dose 
rate in a swimming pool with contamination of 30 ppb malathion to a 7 yo child during a 
3 hour work-out is about:  0.003 mg/kg/day, or 0.1 mg total.  Thus, swimming pool 
exposure to malathion in this model is about 70 times less than the REL, yielding a 
hazard index of 0.015. These preliminary data, with key assumptions, indicate that 
exposure to aqueous malathion at this concentration in this model is not appreciably 
absorbed, and therefore, it is not a public health hazard. 
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Chapter Five 
 
Significance of Research 
 
It is interesting to note that many factors in a swimming pool exposure model may 
actually enhance Kp over published values. For example, increased water retention in the 
stratum corneum layer, increased skin surface temperature and increased skin blood flow 
from exercise all tend to increase Kp. For lipid soluble substances like malathion, 
lowered viscosity of tissue lipids at higher temperatures reduces activation energies for 
diffusion. In addition, sunburned or wounded skin accelerates dermal absorption.  
Finally, skin sites in children appear to be more permeable than skin sites in adults.  Most 
of these factors are operational in the swimming pool model in a way that tends to 
increase the dermal absorption of malathion.  
 
Nevertheless, the main area of uncertainty in the swimming pool exposure model is 
within the estimate for Kp-malathion.  Unfortunately, specific experimental data for Kp-
malathion do not exist.  Fortunately, Kp has been determined for similar compounds in dilute 
aqueous solutions such as ethylbenzene, styrene, and toluene, all of which were 
determined to have similar values to the Kp used for malathion above. Further 
experimental determination of Kp-malathion as used in Bogen’s dermal exposure equations is 
necessary before models for toxic exposures in dilute aqueous solutions of malathion 
while bathing are convincing. 
 
The balance of malathion and malaoxon exposure in humans may be swayed by 
concomitant exposure to exogenous malaoxon. Swimmers may be exposed to malaoxon 
in addition to malathion as the aerial bait lands in the swimming pool and is oxidized by 
its chlorine to this much more potent active metabolite. Let’s recalculate the dermal 
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absorption for the 7yo swimmer, except this time assuming exposure to 30 ppb malathion 
+ 30 ppb malaoxon. 
 
Ds = Kp*Dc*De*Fs*As *Sys/ Mb 
 
Note that the chosen concentrations of malathion and malaoxon are within one standard 
deviation of the mean actual California swimming pool data, and are both well within the 
UCL values.  In addition, let’s use potency of malaoxon = 68 * malathion. 
 
• Kpmalathion = permeability constant across the skin = 0.0010 L/cm2/hr; 
• Kpmalaoxon = permeability constant across the skin = 0.0005 L/cm2/hr; 
• Dc = concentration of malathion in water  = 30 mcg/L or 30 ppb;  
• Dc = concentration of malaoxon in water  = 30 mcg/L or 30 ppb;  
• De = duration of contact with contaminated water = 3 hr; 
• Fs = fraction of skin in contact with water   = 1.0; 
• As = exposed skin surface area   = 12 000 cm2; 
• Mb = body mass     = 34.5 kg; 
• Sys = Dermal absorption to Systemic absorption = 0.10. 
 
Assuming Kp-malathion and Kp-malaoxon  are reasonable, the specific dose rate in a swimming 
pool with contamination of 30 ppb malathion and 30 ppb malaoxon to a 7 yo child during 
a 3 hour work-out is about: 0.11 mg/kg/day, or about 3.8 mg total. Important assumptions 
in this first pass analysis include swimmers first showering with soap and water after 
three hours of swimming, in effect mechanically removing malathion and malaoxon from 
the skin surface-epidermis layer, then secondly moving into environmental settings 
conducive to dermal layer malathion and malaoxon evaporation over the remainder of the 
day. This swimming pool model dosage for malathion + malaoxon is about half the 
adjusted REL, yielding HI = 0.5. Therefore, by definition, this dose may be sufficiently 
close enough to HI = 1 to cause a specific ailment or disease related to malathion toxicity, 
and further analysis is warranted.  
  
45 
Chapter Six 
 
Methods 
 
Background:  Historical studies have measured human dermal uptake of related aromatic 
chemicals from aqueous solutions, using the “disappearance method” in concert with the 
analysis of excreted metabolites. In all the studies that examined uptake from aqueous 
solutions using the disappearance method, both whole hands of each person was 
immersed for two hours in a one-liter beaker. For example, disappearance measurements 
of aqueous ethylbenzene at 125 ppm were compared to the absorbed amount computed 
by utilizing the urine metabolite mandelic acid. Chemical flux into skin was validated as 
the difference in chemical mass contained in the exposure solution at the beginning and 
end of the exposure period, divided by the corresponding dermal surface area 
(Dutkiewicz and Tyras, 1967).   
 
Design:  Prospective, controlled, and limited dermal exposure of hands and forearms of 
human volunteers to dilute aqueous solutions of 50-ppb (mcg/l) malathion in a laboratory 
setting.  
 
Measurements:  EPA-approved, commercial assays to 0.5-ppb (mcg/l) malathion will be 
utilized in order to measure the concentrations in water before and after hand and forearm 
exposure.  
 
Subjects:  Twenty volunteers 
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Test Solution:  Twenty liter tanks were prepared with dilute aqueous solutions of 50-ppb 
(mcg/l) malathion. The solution was prepared by placing 1 mg of laboratory grade 
malathion (Supelco PS86, Malathion, Neat) into the distilled water bath. 
 
A Standard Operating Procedure (SOP) was carefully developed, documented and 
verified to ensure volunteer subject safety. Several quality assurance based trial runs were 
undertaken prior to the first volunteer subject exposure period. During each trial run, each 
twenty liter tank prepared under the SOP was verified to contain a 50-ppb malathion 
concentration via an EPA-approved, commercial assay sensitive to 0.5 ppb. During the 
quality control evaluation period, the tank malathion concentrations were verified to be 
within ±30% (±15 ppb) of the nominal target concentration (50 ppb or 50 mcg/L). 
 
The malathion exposure tank was stagnant, hand-stirred, and then mechanically stirred 
during three different stirring exposure phases of the protocol. The tanks were at room 
temperature (21°C) and swimming pool temperature (29°C or 90°F) during two different 
temperature exposure phases of the protocol as well. Volunteer exposure time was 
gradually increased during several different phases of the protocol from 30 minutes to 
120 minutes. All upward adjustments in exposure level were carefully made in series to 
ensure maximum volunteer safety.  
 
Method:  Subjects place both hands and forearms (total body surface area: Fs = 0.11) into 
a dilute aqueous 50-ppb (mcg/l) malathion solution for up to two (2) hours. Malathion 
solution assays are then made via the “disappearance method” on the tank solution before 
and after the exposure period. 
 
Malathion assays are completed by passing the tank exposure solution through 
Bakerbond C18 Speedisks (Part Number 8055-06). Five hundred milliliters of the 
exposure solution is drained through the Speedisk via full vacuum suction (about 25 mm 
Hg) applied to a Speedisk extraction station (for about five minutes). The Speedisks with 
extracted malathion solute were then shipped in a sealed container to Ecology and 
Environment, Inc., for completion of the EPA assay method.  
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Precise concentrations in the dilute aqueous malathion solution were determined before 
and after exposure using EPA SW-846 Method 8270C at Ecology and Environment, Inc 
(Lancaster, NY). This EPA-approved commercial assay method is sensitive to 0.5 ppb. 
The semi-volatile compound is introduced from a sample extract into the gas 
chromatograph by direct injection of 2 mcl of the extract. Sample extracts are prepared 
for analysis by transferring a measured aliquot of extract to an autosampler vial and 
adding the appropriate amount of internal standard solution. Chromatographic conditions 
are such that the compounds are separated by the gas chromatograph. The compounds are 
detected using a mass spectrometer from which both qualitative and quantitative 
information is obtained. Quantitation is by the internal standard technique using relative 
response factors. 
 
Calculations of chemical flux into skin from the exposure solution are estimated 
according to Fick’s Law as the difference in chemical mass contained in the exposure 
solution at the beginning and end of the exposure period, divided by the corresponding 
exposed dermal surface areas. In summary, a Mass Balance System was implemented 
upon the exposure solution, with the assumption that all lost malathion in solution was 
driven down the concentration gradient into the exposed human subject. Kp-malathion 
(permeability constant across the skin) was then derived from the actual Fs=0.11 
exposure model. Kp-malathion was then theoretically applied to an Fs = 1.00 swimming pool 
model for both theoretical child and adult swimming pool models. Finally, hazard index 
(HI) for theoretical three-hour swimming pool exposures were calculated based upon 
experimentally derived Dd and Kp-malathion values.   
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Table 15: Parameters for Kp = Dd*Mb / (Dc*De*Fs*As). 
• Dd = skin dosage of malathion absorbed in mcg 
• Dc = average concentration gradient of malathion from water to skin  
• De = duration of contact with contaminated water 
• Fs = fraction of skin in contact with exposure solution   = 0.11; 
• Fsadj = adjustment for Maibach’s relative skin absorption   = 0.0775; 
• Fs = fraction of skin in contact with water in swimming pool  = 1.00; 
 
Table 16: Parameters for Ds = Kp*Dc*De*Fs*As*Sys / Mb. 
Adult: 
• As = total skin surface area      = 21 345 cm2;  
• Mb = body mass        = 85 kg;  
• HI = Ds  / (0.2 mg/kg/day)*(85 kg)     = Ds / 17 mg;  
Child: 
• As = exposed skin surface area     = 12 000 cm2; 
• Mb = body mass       = 34.5 kg; 
• HI = Ds  / (0.2 mg/kg/day)* (34.5 kg)    = Ds / 7 mg; 
 
Example Calculation:  Utilize the theoretical exposure model Dd = Kp*Dc*De*Fs*As / 
Mb, and assume approximate Kp-malathion = 0.001 L/cm2/hr. An 85 kg subject typically has 
hand area Fs=.025 (each) and forearm area Fs=.03 (each). Therefore, immersing both 
hands and forearms in the malathion solution yields a total exposure area Fs=.11, with 
Fsadj = 0.0775 after adjustment for Maibach’s relative skin absorption data. Therefore, 
this theoretical volunteer would dermally, but not systemically, absorb: 
 
Dd = (.001 L/cm2/hr)(50 ppb or mcg/l)(3 hr)(.0775)(21 345 cm2) = 248 mcg. 
 
The 20 liter immersion tank, then, would change from the original concentration of 50 
ppb malathion to 37.6 ppb (mcg/l) or (1000 mcg - 248 mcg) / 20 liters. This change in 
malathion concentration over the time period of the volunteer subject exposure period is 
well within the sensitivity of the NIOSH/EPA laboratory assay procedure.  
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Chapter Seven 
 
Volunteer Safety 
 
Screening of Volunteer Subjects:  Each female participant had a proven negative 
pregnancy test within 72 hours of study participation. Each volunteer subject was 
screened for a history of acute or chronic disease or disability, Gulf War Syndrome, or 
previous significant exposure to malathion, organophosphate or other pesticide. If the 
screening history is positive, the subject is eliminated from participation in the study 
protocol. 
 
Medical Observation:  Each subject is intermittently observed for acute cholinergic signs 
and symptoms by a licensed physician during the two (2) hour experimental protocol 
period as follows: 
• Mild exposure symptoms include headache, giddiness, dizziness, anxiety, weakness, 
tremors of tongue and eyelids, and miosis. 
• Moderate exposure symptoms include behavioral disturbances, sweating, nausea, 
vomiting, salivation, lacrimation, diarrhea, paresthesias, muscle tremors, and in-
coordination. 
• Severe exposure symptoms include fecal and urinary incontinence, pulmonary edema, 
heart block, respiratory failure, convulsions, coma and death. 
 
Although highly unlikely at the malathion dosage selected for use in this experimental 
protocol, a volunteer exhibiting signs or symptoms of organophosphate exposure would 
be referred to a local emergency room for treatment at once. In addition, a resuscitation 
cart equipped for atropine and pralidoxime (2-PAM) administration was immediately 
available for use by a licensed physician should emergency reversal of 
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cholinergic events become necessary. Furthermore, volunteers exhibiting any cholinergic 
signs or symptoms would be reported as an adverse event to the Institutional Review 
Board at once. 
 
Hazard Index Model: Worst-case-scenario analysis assumes the subject volunteer 
absorbs all the malathion in the exposure tank, 1 mg, or 12 mcg/kg/day. Since the 
Reference Exposure Level is 200 mcg/kg/day, Hazard Index = 12/200 or 0.06. Therefore, 
health protection is achieved since the estimated dosage is an order of magnitude below 
the relevant REL and HI << 1. 
 
Biological Exposure Indices: The ACGIH recommended BEI for organophosphorus 
cholinesterase inhibitors (e.g. malathion) is RBC Cholinesterase Activity. Significant 
exposure is widely recognized to have occurred if RBC Cholinesterase activity is 
decreased more than 30% from an individual’s baseline condition. Continued depression 
may occur in dose-dependent fashion for up to 12 weeks post-exposure. RBC 
cholinesterase activity is the preferred measure as it is the same enzyme found within the 
nervous system.  
 
In Moeller and Rider’s NOAEL / LOAEL landmark malathion study, the defined 
objective was to determine the maximum amount of malathion which can be ingested 
daily for a prolonged period of time without depressing the pretest level of RBC 
Cholinesterase Activity. The subjects were healthy men in San Quentin State Prison. 
Malathion was orally administered at 8 mg/day for 32 days, 16 mg/day for 47 days, and 
24 mg/day for 56 days. RBC Cholinesterase was analyzed at baseline then twice weekly. 
Neither 8 mg/day nor 16 mg/day affected RBC Cholinesterase Activity in a statistically 
significant manner. However, 24 mg/day for 56 days depressed RBC Cholinesterase 
Activity to about 75% of baseline.  
 
Based upon Moeller and Rider’s study, BEI monitoring with RBC Cholinesterase 
Activity during this protocol appears unwarranted. That is, in the worst case scenario, the 
volunteer subject would absorb all the malathion in the exposure tank: 1 mg. This dosage 
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is well below the known dosage to cause RBC Cholinesterase depression. Furthermore, 
volunteer subjects in this protocol have only a single exposure. In the Moeller and Rider 
study, volunteer subjects required 24 mg oral ingestion exposures on 56 consecutive days 
before RBC Cholinesterase was depressed.    
 
Dermal Exposure Indices:  Dermal absorption of neat malathion (24.6 mg), a 50% 
emulsifiable concentrate (25.7 mg), and a 1% (0.16 mg) and 10% (5.5 mg) aqueous 
mixture was examined in human volunteers. Each volunteer subject received a single 
application of the nominal dose of malathion applied to a 4.6 cm2 area of the ventral 
forearm. The 1.0% aqueous mixture appeared to be more readily absorbed than the other 
formulations: 6.42% of the external concentration was absorbed per hour (Dary, 1994). 
Based upon this study analysis, <20% of the dilute malathion aqueous experimental 
solution will be absorbed after 2 hours time by the volunteers, or about 0.2 mg of 
Malathion. This dosage of malathion is well under the Reference Exposure Level (REL) 
and Hazard Index (HI) for Malathion 
 
Theoretical Mathematical Exposure Model: Utilizing the exposure model described once 
again with assumed Kp-malathion =0.001 L/cm2/hr, and the formula Ds = 
Kp*Dc*De*Fsadj*As*Sys / Mb, the subject volunteers in the protocol will be exposed to 
about: 
 
Ds = (.001 L/cm2/hr)(50 ppb)(3 hr)(.0775)(21 345 cm2)(0.10) / (85 kg); 
= 25 mcg / 85 kg adult; 
= 0.3 mcg/kg/day. 
Reference Exposure Level (REL) = 200 mcg/kg/day; 
Hazard Index (HI) = 0.3 / 200 = 0.0015. 
 
Therefore, health protection is achieved since the estimated dosage is below the relevant 
REL and the HI is << 1. 
 
  
52 
Over-the-counter Exposure Model: Household over-the-counter malathion formulations 
(Spectracide®, manufactured for Spectrum Group, United Industries Corporation, St. 
Louis, EPA Reg. No. 10370-291-8845) are available in 50% xylene solution, or 500 
mg/ml. The worst-case-scenario exposure of a subject volunteer in this protocol is 
equivalent to exposure to about 1/500 ml or 0.002 ml of the over-the-counter solution.  
 
Carcinogen Status:  At the time of the study protocol approval, malathion was not 
classified as a carcinogen by any certified organization including the ACGIH. 
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Chapter Eight 
 
Results 
 
 
Table 17: General Experimental Results. 
 
• Demographics: All volunteer subjects were between ages 25-50 yo, weight 70 – 
100 kg, and 2/20 (10%) were female.  
• Subject eleven was removed from further data analysis due to the null 
concentration of malathion during the exposure period. 
• Eight of nineteen subjects (42%) absorbed no malathion from solution, thus 
receiving no malathion dosage during exposure.  
• Eleven of nineteen subjects (58%) absorbed malathion from solution, thus 
receiving a malathion dosage during exposure.  
• Begin versus end malathion concentrations were highly variable from volunteer to 
volunteer, but not significantly different (p = 0.185).  
• Volunteer Safety: No volunteer experienced signs or symptoms of 
organophosphate exposure or toxicity at any time.  
• Experimental Kpmalathion derived from human volunteer exposures ranged from 0 - 
0.0051 L/cm2/hr (ave=0.0005, SD=0.0011, UCL=0.0028). 
• Hazard Index (HI) for adult swimmers immersed for three hours in Malathion=30 
ppb+Malaoxon=0 ppb (utilizing experimentally-derived Kpmalathion) ranged from 0 
– 0.06 (ave=0.01, SD=0.01, UCL=0.03). 
• Hazard Index (HI) for child swimmers immersed for three hours in Malathion=30 
ppb+Malaoxon=0 ppb (utilizing experimentally-derived Kpmalathion) ranged from 0 
– 0.08 (ave=0.01, SD=0.02, UCL=0.04). 
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• Hazard Index (HI) for adult swimmers immersed for three hours in Malathion=30 
ppb+Malaoxon=30 ppb (utilizing experimentally-derived Kpmalathion) ranged from 
0 – 2.0 (ave=0.21, SD=0.45, UCL=1.11). 
• Hazard Index (HI) for child swimmers immersed for three hours in Malathion=30 
ppb+Malaoxon=30 ppb (utilizing experimentally-derived Kpmalathion) ranged from 
0 – 2.8 (ave=0.29, SD=0.62, UCL=1.53). 
 
Table 18:  Dermal Absorption by Volunteer - I
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Table 19: Dermal Absorption by Volunteer - II
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Table 20:  Dermal Absorption by Dosage
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Table 21: Dermal Absorption by Kp-malathion
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Table 22:   Hand / Forearm Exposure in Aquarium;  
Nominal Contamination: Malathion=50 ppb + Malaoxon=0 ppb; 
Disappearance Method: Solution Concentrations. 
 
subject   pre-  post-  stir  temp  time   
   malathion malathion     
(mcg/l) (mcg/l)   (°C)  (min)      
 1     38.6    31.2   no   21    30  
 2     51.6    52.6   no   21    60    
 3     46.8    43.6   no   21    60  
 4     40.4    37.2   no   21    90  
 5     42.4    44.0   no   21    90   
 6     50.0    48.4   no   21    90  
 7     39.2    36.6   no   21  135  
 8     32.4    34.8   no   21  135   
 9     47.2    45.6   no   21  135  
10     68.0    60.0  yes   21  120  
11       0.0      0.0  yes   21  120   
12              126.0             108.0  yes   21  120  
13     46.0    46.0  yes   21  120   
14     46.0    46.0  yes   21  120  
15     44.0    46.0  yes   21  120  
16     50.0    48.0  yes   29  120  
17     56.0    52.0  yes   29  120  
18     34.0    48.0  yes   29  120  
19     50.0    50.0  yes   29  120  
20     50.0    44.0  yes   29  120 
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Table 23:   Hand / Forearm Exposure in Aquarium; 
Nominal Contamination: Malathion=50 ppb + Malaoxon=0 ppb; 
Disappearance Method: Experimental determination of Kpmalathion.    
 
subject    Skin   Kp-malathion   
   Dosage   
(Dd in mcg)  (L/cm2/hr) 
 1     148   .00513   
 2          0   0    
 3       64   .00086    
 4       64   .00067    
 5         0   0    
 6       32   .00026    
 7       52   .00037    
 8          0   0  
 9       32   .00019    
10     160   .00076    
11            0   0    
12                360   .00093    
13           0   0    
14            0   0    
15            0   0    
16        40   .00025   
17        80   .00045   
18            0   0    
19            0   0    
20     120   .00077   
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Table 24:   Swimming Pool Model using experimental Kpmalathion; 
Contamination: Malathion=30 ppb + Malaoxon=0 ppb; 
Adult Swimmer immersed for three hours. 
 
subject   Skin   Systemic  Hazard    
Dosage  Dosage  Index    
(Dd in mg)  (Ds in mg)    
 1  9.85   1.0   0.06  
2 0   0   0    
3 1.64   0.2   0.01    
 4  1.28   0.1   0.01   
 5  0   0   0 
6  0.50   0.05   0.003     
 7  0.71   0.1   0.004    
8 0   0   0  
9 0.36   0.04   0.002    
10 1.45   0.1   0.01 
11 0   0   0    
12 1.79   0.2   0.01    
 13  0   0   0 
 14  0   0   0  
 15  0   0   0  
 16  0.47   0.05   0.003    
 17  0.86   0.1   0.005    
 18  0   0   0 
 19  0   0   0 
 20  1.48   0.1   0.01    
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Table 25:   Theoretical Swimming Pool Model using experimental Kpmalathion; 
Contamination: Malathion=30 ppb + Malaoxon=0 ppb; 
Child Swimmer immersed for three hours. 
 
subject   Skin    Systemic  Hazard    
Dosage  Dosage  Index    
(Dd in mg)  (Ds in mg)    
 1  5.54   0.5   0.08  
2  0   0   0    
3  0.92   0.1   0.01    
 4  0.72   0.1   0.01   
 5  0   0   0 
6  0.28   0.03   0.004     
 7  0.40   0.04   0.006    
8  0   0   0  
9  0.20   0.02   0.003    
10  0.82   0.08   0.01 
11  0   0   0    
12  1.00   0.1   0.01    
 13  0   0   0 
 14  0   0   0  
 15  0   0   0  
 16  0.27   0.03   0.004    
 17  0.48   0.05   0.007    
 18  0   0   0 
 19  0   0   0 
 20  0.83   0.08   0.01  
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Table 26:   Theoretical Swimming Pool Model using experimental Kpmalathion; 
Contamination: Malathion=30 ppb + Malaoxon=30 ppb;  
Adult Swimmer immersed for three hours. 
 
subject   Skin   Systemic  Hazard    
Dosage  Dosage  Index    
(Dd in mg)  (Ds in mg)    
 1  345   34.5   2.0  
2     0     0   0    
3   57     5.7   0.3    
 4   45     4.5   0.3   
 5     0     0   0 
6   18     1.8   0.1    
 7   25     2.5   0.2    
8     0     0   0  
9  12     1.2   0.1    
10  51     5.1   0.3 
11    0     0   0    
12  63     6.3   0.4    
 13    0     0   0 
 14    0     0   0  
 15    0     0   0  
 16  17     1.7   0.1    
 17  30     3.0   0.2    
 18    0     0   0 
 19    0     0   0 
 20  52     5.2   0.3    
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Table 27:   Theoretical Swimming Pool Model using experimental Kpmalathion; 
Contamination: Malathion=30 ppb + Malaoxon=30 ppb;  
Child Swimmer immersed for three hours. 
 
subject   Skin   Systemic  Hazard    
Dosage  Dosage  Index    
(Dd in mg)  (Ds in mg)    
 1  194   19   2.8  
2      0     0   0    
3    32     3.2   0.5    
 4    25     2.5   0.4   
 5     0     0   0 
6   10     1.0   0.1    
 7   14     1.4   0.2    
8     0     0   0  
9     7     0.7   0.1    
10   29     2.9   0.4 
11     0     0   0    
12   35     3.5   0.5   
 13     0     0   0 
 14     0     0   0  
 15     0     0   0  
 16     9     0.9   0.1   
 17   17     1.7   0.2    
 18     0     0   0 
 19     0     0   0 
 20   29     2.9   0.4  
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Chapter Nine 
 
Discussion 
 
It is not uncommon in dermal absorption studies for wide Kp variation within individual 
experimental results. Absorption constants and as a result dosage received can vary by 
several orders of magnitude between human subjects. For example, during this protocol, 
eight of nineteen subjects absorbed nil malathion, or at least so little that no absorption 
could be detected by the disappearance technique. In contrast, the absorption constant 
derived from the first volunteer was an order of magnitude greater than the following 
nineteen subjects, this despite the most conservative set of experimental conditions. This 
wide variation in results is similar to other investigators experience in similar published 
dermal absorption study settings.  
 
As compared to malathion and malaoxon, toluene and chloroform are smaller in 
molecular weight but with similar oil-water partition coefficients. Thus, according to 
Bogen’s equation, toluene and chloroform should have considerably larger permeability 
constants (Kp). However, the experimentally derived Kpmalathion= .0005 L/cm2/hr 
obtained in this study is in fact similar to those previously obtained by other investigators 
for Kptoluene=.0008 L/cm2/hr  and Kpcholoroform= 0.0001 L/cm2/hr. 
 
It is interesting to note that many factors in the swimming pool exposure model may 
enhance the typical Kpmalathion,. For example, water, ambient, and skin temperatures may 
well be greater in swim exercise. These increased temperatures enhance skin absorption. 
Also, during swimming or bathing, greater hydration of skin surfaces takes place, again 
promoting Kp. For lipid-soluble malathion, lowered viscosity of tissue lipids at higher 
temperatures reduces activation energies needed for diffusion. In addition, sunburned or 
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wounded skin, as well as hair follicles and sweat glands, accelerate dermal absorption. 
Finally, skin sites in children appear to be more permeable than skin sites in adults. Thus, 
the experimental Kpmalathion derived from this study is likely a conservative value.  
 
Utilizing the experimentally-derived Kpmalathion, the Hazard Index (HI) for adult and child 
swimmers immersed for three hours in a malathion only contaminated pool ranged from 
0 – 0.08. These data indicate that exposure to dilute aqueous malathion solutions 
following usual aerial bait applications is not appreciably absorbed, and therefore, not a 
public health hazard. 
 
Importantly, a potential problem arises in the analysis from the statement ‘usual aerial 
bait application’. An atypical problem scenario exists with aerial bait application in that 
malathion is easily oxidized to the more potent malaoxon by chlorine within swimming 
pools. This fact is evidenced by the fact that both California and Florida environmental 
agencies and public health authorities found considerable malaoxon contamination of 
public and private swimming pools in the days and weeks following aerial bait 
application. 
 
In vivo, parent malathion must be metabolically activated to malaoxon by oxidative 
desulfuration to be an effective AChE inhibitor. This activation step is carried out by both 
mammals and insects, but insects are relatively deficient in the carboxylesterases used by 
mammals for detoxification. Thus, insects have higher toxicity to malathion generally 
speaking. However, humans may have similar malathion toxicity profiles to insects if and 
when liver carboxylesterase is inactivated. One compound well known to inactivate liver 
carboxylesterase is malaoxon, which may do so if absorbed ex vivo from contaminated 
swimming pools.   
 
Since malaoxon is 68 times as toxic as malathion, human volunteer exposure to same, 
with or without concurrent exposure to malathion, is generally deemed too dangerous for 
human experimentation. Therefore, in order to analyze the potential toxicity of external 
malaoxon contamination and exposure in the swimming pool model, it is necessary to 
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estimate Kpmalaoxon. Fortunately, Bogen’s empirical formula for Kp values based upon 
molecular weight and oil-water partition coefficient values can be utilized for same. In 
this case, owing to the more polar qualities of malaoxon, Kpmalaoxon is estimated to be 
one-half that of Kpmalathion.    
 
The Hazard Index for swimmers immersed for three hours in a malathion plus malaoxon 
contaminated pool was modeled utilizing the experimentally-derived Kpmalathion, and 
Bogen’s technique to estimate Kpmalaoxon. This methodology yielded an average HI=0.21 
for adult swimmers, with HI for child swimmers similarly averaging 0.29. Although 
HI>1 (albeit slightly) at the UCL (two standard deviations) for the volunteer group 
modeled in this malathion plus malaoxon exposure model, even these data indicate there 
is no appreciable public health hazard.   
 
In order to lessen uncertainty in the hazard index estimate for malathion plus malaoxon 
exposure scenarios, further animal or human experimental dermal absorption data is 
clearly indicated in order to determine Kpmalaoxon with more certainty. Since human 
volunteers should not be utilized in experiments with this toxic compound, the next best 
available alternative is hairless guinea pig skin. Bogen and others have determined that 
the hairless guinea pig is a superb model for human dermal skin absorption, and a similar 
disappearance method to that used in this protocol can be effectively used with this 
guinea pig animal model. Thus, potentially synergistic contaminant toxicity profiles for 
malathion plus malaoxon may be more precisely determined in the future (Bogen, 1992). 
 
Additional routes of entry for malathion and its co-products to enter into a swimmers 
body exist but have not yet been integrated within the theoretical model described in this 
paper. EPA estimates that children who swim for 3 hours daily take in and squirt out of 
their mouths 16 liters of pool water and ingest 1% of that amount. The residence time for 
each 5 ml aliquot in the mouth will be about 1.75 seconds, and during this time period 
about 1% of the malathion will be absorbed through the buccal and sublingual mucous 
membranes. Additional absorption is possible again through the orbital, nasal, aural, and 
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inhalation routes. These unaccounted for routes of ingestion, absorption, and inhalation in 
the swimmer may increase total dosage exposure scenarios by up to 50%. 
 
The most neglected aspect of pesticide toxicity investigation in mammals remains 
zeroing in on the toxicity of breakdown products of the parent compound. In fact, the 
toxicity profile of mixtures of parent and breakdown products may be synergistic in 
nature. Measurements of skin absorption rely on data obtained from single compound 
solutions. This technique may underestimate absorption in the more common scenario of 
multiple exposures to solvent mixtures in the contaminated water. Studies show that 
combinations of compounds have greater effect on the stratum corneum, and are 
absorbed more readily. In addition, potent impurities such as malaoxon, isomalathion, 
O,O,S-trimethyl phosphorothioate and diethyl fumarate may contribute synergistically to 
the toxicity of technical malathion formulations both before and after usual aerial bait 
application (Aldridge, 1979). For example, a difference of a day or two in bait application 
on two adjacent areas could result in a condition in which a considerable quantity of the 
breakdown product along with a substantial quantity of the parent compound could be 
washed by rainfall into the common water source. In a single body of water, daily pH 
fluctuations could conceivably be responsible for producing synergistic conditions as 
well. The rapid production of diethyl fumarate could occur during the period when pH is 
high, its rate of production being reduced after the active photosynthetic period, leaving 
enough malathion to produce synergistic toxic effects (Bender, 1969).        
 
These data suggest that the toxic exposure profile of the population swimming in the 
spray area may be significantly different than the profile measured in the original bait 
spray tank. As a minimal standard, prior to spray application, analysis should be 
considered for potent and toxic contaminants (e.g. isomalathion, malaoxon, diethyl 
fumarate) within the technical malathion formula. In addition, after spray application, 
similar analysis should be considered for swimming pools within these same designated 
spray areas. In fact, partially as a result of this type of analysis, California ultimately cut 
its target aerial spray malathion concentrations from 2.4 to 1.2 ounces per acre, then 
subsequently abandoned malathion completely in favor of biological controls in 1994. 
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Chapter Ten 
 
Conclusion 
 
Malathion skin absorption measured among 58% of the human volunteers by the 
disappearance method allowed for experimental determination of Kpmalathion=.0005 
L/cm2/hr. The dosage in human volunteers from this controlled exposure to a 
contaminated aquarium solution was several orders of magnitude less than the minimal 
dose necessary to cause measurable change in red blood cell acetylcholinesterase (RBC-
AChE). Following experimental determination of Kpmalathion, a mathematical model was 
evaluated for swimmers using dilute aqueous malathion contamination concentrations 
typically detected after bait application. Extrapolation of Kpmalathion into swimming pool 
exposures (both adults and children, with and without malaoxon) resulted in dosages an 
order of magnitude below that needed to cause a detectable change in RBC-AChE. These 
data indicate that exposure to aqueous malathion following usual aerial bait applications 
is not appreciably absorbed, and therefore, not a public health hazard. 
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